Viva Biotech Holdings
VBIZF
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.21B
Close$
Share Statistics
| Market cap | $3.21 Billion |
|---|---|
| Enterprise Value | $3.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.1 |
| Beta | 1.38 |
| Outstanding Shares | 2,104,969,000 |
Return
| Return on Equity | 8.80% |
|---|---|
| Return on Assets | 5.06% |
| Return on Invested Capital | 7.29% |
Valuation & Multiples
| P/E Ratio | 16.02 |
|---|---|
| PEG | -46.76 |
| Price to Sales | 0.19 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | 7.45 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Viva Biotech Holdings
2,213 employees
CEO: Chen Cheney Mao Viva Biotech Holdings, founded in 2008 and based in Shanghai, China, operates as an investment holding company primarily dedicated to providing comprehensive, structure-based drug discovery services to biotechnology and pharmaceutical cl...